Clinical Trial Update: A Post Marketing Study in Participants With Early Alzheimer's Disease Treated With Lecanemab

View source ↗

Summary

A post-marketing study in participants with early Alzheimer's disease treated with lecanemab is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Lecanemab (lecanemab)

Snippet

Sponsor: Eisai Co., Ltd. | Conditions: Alzheimer's Disease | Status: RECRUITING